MALIGNANT JOINT NEOPLASM

MALIGNANT JOINT NEOPLASM was reported 16 times

MALIGNANT JOINT NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
1 Muscle Relaxant [EPC] 1 0.0000
2 Janus Kinase Inhibitor [EPC] 2 0.0000
3 Microtubule Inhibitor [EPC] 2 0.0000
4 Integrin Receptor Antagonist [EPC] 1 0.0000
5 Prostaglandin Analog [EPC] 1 0.0000
6 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
7 Platinum-based Drug [EPC] 2 0.0000
8 Expectorant [EPC] 1 0.0000
9 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
10 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
11 Loop Diuretic [EPC] 1 0.0000
12 Thalidomide Analog [EPC] 1 0.0000
13 Proton Pump Inhibitor [EPC] 1 0.0000
14 Corticosteroid [EPC] 1 0.0000